These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33500663)

  • 1. GSG2 Promotes Development and Predicts Poor Prognosis of Ovarian Cancer.
    Huang Y; Liu Y; Zhu K; Ma X; Lu R; Zhang M
    Cancer Manag Res; 2021; 13():499-508. PubMed ID: 33500663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haspin knockdown can inhibit progression and development of pancreatic cancer in vitro and vivo.
    Han X; Kuang T; Ren Y; Lu Z; Liao Q; Chen W
    Exp Cell Res; 2019 Dec; 385(1):111605. PubMed ID: 31493385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects and mechanisms of GSG2 in esophageal cancer progression.
    Geng C; Wang Q; Xing PF; Wang M; Tong SD; Zhou JY
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3409-3421. PubMed ID: 35939116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GSG2 promotes tumor growth through regulating cell proliferation in hepatocellular carcinoma.
    Li L; Li S; Wang H; Li L; Wang P; Shen D; Dang X
    Biochem Biophys Res Commun; 2022 Oct; 625():109-115. PubMed ID: 35952607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GSG2 (Haspin) promotes development and progression of bladder cancer through targeting KIF15 (Kinase-12).
    Chen Y; Fu D; Zhao H; Cheng W; Xu F
    Aging (Albany NY); 2020 May; 12(10):8858-8879. PubMed ID: 32439830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germ cell-specific gene 2 accelerates cell cycle in epithelial ovarian cancer by inhibiting GSK3α-p27 cascade.
    Zhu K; Ma X; Guan X; Tong Y; Xie S; Wang Y; Zheng H; Guo L; Lu R
    J Mol Histol; 2024 Jun; 55(3):241-251. PubMed ID: 38613588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lncrna FGFR3-AS1 Is a Prognostic Indicator for Ovarian Cancer and Induces Cell Proliferation and Hinders Apoptosis.
    Zhang Y; Sun L; Chen T; Yue Y; Zhao L; Zhang D
    Iran J Public Health; 2023 Nov; 52(11):2412-2416. PubMed ID: 38106830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GSG2 knockdown suppresses cholangiocarcinoma progression by regulating cell proliferation, apoptosis and migration.
    Zhou J; Nie W; Yuan J; Zhang Z; Mi L; Wang C; Huang R
    Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of GSG2 inhibits prostate cancer progression in vitro and in vivo.
    Yu F; Lin Y; Xu X; Liu W; Tang D; Zhou X; Wang G; Zheng Y; Xie A
    Int J Oncol; 2020 Jul; 57(1):139-150. PubMed ID: 32319597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of
    Yu W; Liu W; Feng Y; Zhu C
    Genet Test Mol Biomarkers; 2022 Jan; 26(1):26-36. PubMed ID: 35089075
    [No Abstract]   [Full Text] [Related]  

  • 11. GSG2 promotes thyroid cancer via stabilizing AURKB and activating AKT pathway.
    Zhang F; Huang C
    Aging (Albany NY); 2024 Mar; 16(6):5091-5107. PubMed ID: 38441546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatic Analysis Reveals GSG2 as a Potential Target for Breast Cancer Therapy.
    Ye Z; Zhang Z; Fang L; Tian D; Liu X
    Open Life Sci; 2019 Jan; 14():688-698. PubMed ID: 33817208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
    Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CBX3 promotes glioma U87 cell proliferation and predicts an unfavorable prognosis.
    Zhao SP; Wang F; Yang M; Wang XY; Jin CL; Ji QK; Li S; Zhao XL
    J Neurooncol; 2019 Oct; 145(1):35-48. PubMed ID: 31502042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HASPIN is involved in the progression of gallbladder carcinoma.
    Zhu D; Gu X; Lin Z; Yu D; Wang J; Li L
    Exp Cell Res; 2020 May; 390(2):111863. PubMed ID: 31987787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation-dependent modulator of Gsg2/Haspin gene expression.
    Sato S; Maeda C; Hattori N; Yagi S; Tanaka S; Shiota K
    J Reprod Dev; 2011 Sep; 57(4):526-33. PubMed ID: 21606629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
    Zeng S; Liu S; Feng J; Gao J; Xue F
    Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIF15 facilitates gastric cancer via enhancing proliferation, inhibiting apoptosis, and predict poor prognosis.
    Ding L; Li B; Yu X; Li Z; Li X; Dang S; Lv Q; Wei J; Sun H; Chen H; Liu M; Li G
    Cancer Cell Int; 2020; 20():125. PubMed ID: 32322172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ROR2 induces cell apoptosis via activating IRE1α/JNK/CHOP pathway in high-grade serous ovarian carcinoma in vitro and in vivo.
    Li R; Liu T; Shi J; Luan W; Wei X; Yu J; Mao H; Liu P
    J Transl Med; 2019 Dec; 17(1):428. PubMed ID: 31878941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low BCL9 expression inhibited ovarian epithelial malignant tumor progression by decreasing proliferation, migration, and increasing apoptosis to cancer cells.
    Wang J; Zheng M; Zhu L; Deng L; Li X; Gao L; Wang C; Wang H; Liu J; Lin B
    Cancer Cell Int; 2019; 19():330. PubMed ID: 31827404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.